STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.
What does STAT Plus cover?
Here’s the breakdown:
Market-moving biotech analysis — from startup funding to clinical trial readouts
Extensive pharmaceutical coverage — from drug pipelines to boardroom shakeups
The intersection of Capitol Hill, regulatory agencies, and the life sciences
Reporting on scientific breakthroughs driving drug discovery and pipeline development
What's included with a subscription?
Enjoy an exclusive set of benefits, including:
Daily reporting and analysis
The most comprehensive industry coverage from a powerhouse team of reporters
Daily newsletters to brief you on the most important industry news of the day
Exclusive industry events
Regular STAT Plus events and early-bird access to events around the country
Frequent opportunities to engage with veteran beat reporters and outside industry experts
The best reporters in the industry
The most trusted and well-connected newsroom in the health care industry
And much more
Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.